Export Products (Pharmaceuticals)
A) EP(Pharma) Divisions deals with export promotion matters relating to Pharmaceuticals product. The administrative matters pertaining to the Export Promotion Council for Pharma viz. Pharmaceutical Export Promotion council of India (Pharmexcil) are also dealt. The division addresses issues relating to commodities of Pharma sector and promoting exports of commodities of this sector. Imports relating to engineering commodities are also appraised.
B) Details of EP(PHARMA) Divisions Officers:-
- Shri Shyamal Misra- Joint Secretary, Tel:- 23063460 23063443
- Shri K. V Nagi Reddy – Director, Tel:- 23063642
- Shri Bahadur Singh – Consultant
C) Export Data:-
|
India’s Pharma Exports Panel Wise $ million
|
|
Category
|
2015-16
|
2016-17
|
2017-18
|
Change% Fy-18
|
Contbn% Fy-18
|
|
Ayush & Herbal Products
|
363.99
|
401.69
|
455.86
|
13.49
|
2.64
|
|
BULK DRUGS AND DRUG INTERMEDIATES
|
3597.28
|
3383.52
|
3539.38
|
4.61
|
20.49
|
|
DRUG FORMULATIONS AND BIOLOGICALS
|
12647.84
|
12666.44
|
12908.76
|
1.91
|
74.72
|
|
SURGICALS
|
302.9
|
333.36
|
371.81
|
11.53
|
2.15
|
|
Grand Total
|
16912.01
|
16785
|
17275.8
|
2.92
|
100.00
|
(Source: DGCIS)
D) Top 10 export destinations for India for Pharma:-
|
India's Pharma exports to top 10 countries $ Million
|
|
Rank
|
Country
|
2015-16
|
2016-17
|
2017-18
|
Change% Fy-18
|
Contbn% Fy-18
|
|
1
|
U S A
|
5513.78
|
5563.54
|
5116.32
|
-8.04
|
29.62
|
|
2
|
SOUTH AFRICA
|
605.27
|
484.89
|
582.99
|
20.23
|
3.37
|
|
3
|
U K
|
563.76
|
549.81
|
556.70
|
1.25
|
3.22
|
|
4
|
RUSSIA
|
373.76
|
383.46
|
468.74
|
22.24
|
2.71
|
|
5
|
NIGERIA
|
436.61
|
397.99
|
466.67
|
17.26
|
2.70
|
|
6
|
GERMANY
|
347.65
|
333.30
|
388.43
|
16.54
|
2.25
|
|
7
|
BRAZIL
|
326.17
|
337.37
|
383.72
|
13.74
|
2.22
|
|
8
|
KENYA
|
332.48
|
325.43
|
254.62
|
-21.76
|
1.47
|
|
9
|
AUSTRALIA
|
232.78
|
236.87
|
253.80
|
7.15
|
1.47
|
|
10
|
FRANCE
|
231.76
|
208.87
|
251.44
|
20.38
|
1.46
|
|
Total Of top Ten
|
8964.04
|
8821.53
|
8723.43
|
-1.11
|
50.50
|
|
Grand Total
|
16912.01
|
16785
|
17275.8
|
2.92
|
100.00
|
(Source: DGCIS)
E) Exhibitions / events
Exhibitions / events participated in 2017-18
|
Sl. No.
|
Name of the event
|
Date
|
|
1
|
Pharmaconex, Egypt
|
8-10th April 2017
|
|
2
|
Korea Pharm
|
18-21st April 2017
|
|
3
|
CPhI Japan
|
19-21st April 2017
|
|
4
|
IPHEX, India
|
27-29th April 2017
|
|
5
|
CPhI North America, Philadelphia
|
16-18th May 2017
|
|
6
|
CphI China
|
20-22nd June 2017
|
|
7
|
Business delegation to LAC countries
|
27th Aug to 9th Sep 2017
|
|
8
|
CphI Worldwide, Germany
|
24-26th October 2017
|
|
9
|
Business delegation to Cuba
|
30th Oct to 3rd Nov 2017
|
|
10
|
CPhI India
|
28-30th November 2017
|
|
11
|
Arab Health, UAE
|
29th Jan to 1st Feb 2018
|
|
12
|
Business delegation to African countries
|
18-28th Feb 2018
|
|
13
|
Asia Pharma expo, Dhaka
|
8-10th Feb 2018
|
Exhibitions / events proposed to participate in 2018-19
|
Sl. No.
|
Name of the event
|
Date
|
|
1
|
Pharmaconex, Egypt
|
14-16 April 2018
|
|
2
|
Korea Pharm
|
17-20th t April 2018
|
|
3
|
CPhI Japan
|
18-20th April 2018
|
|
4
|
IPHEX, India
|
8-10th May 2018
|
|
6
|
CphI China
|
20-22nd June 2018
|
|
7
|
Business delegation to LAC countries
|
27th Aug to 6th Sep 2018
|
|
8
|
Maghreb Pharma Expo, Algeria
|
17-19th Sep 2018
|
|
9
|
Iran Pharma, Iran
|
24-27th Sep 2018
|
|
10
|
CphI Worldwide, Spain
|
9-11th October 2018
|
|
11
|
Business delegation to CIS Countries
|
17th Nov to 1st Dec 2018
|
|
12
|
CPhI India
|
12-14th December 2018
|
|
13
|
Arab Health, UAE
|
28-31st Jan 2019
|
|
14
|
Business delegation to African countries
|
Jan/Feb 2019
|
F) Section 4 of RTI - Act (Mandatory Disclosures):
Name, Designations and other particulars:
Appellate Authority:
Shri Shyamal Misra,
Joint Secretary,
Department of Commerce,
Room No.-250, Udyog Bhawan,
New Delhi. Ph: 23061139/464
CPIO:
Shri K.V.Nagi Reddy,
Director, Dept. of Commerce
Room No. 285, Udyog Bhawan,
New Delhi. Ph: 23063642
EPCs like Pharmexcil are not covered under the RTI Act provisions. However, for any information directly pertaining to the Council, an applicant can approach the council directly and it generally provides information which are not in conflict with commercial activities of its members. GoI can provide information as per record available pertaining to aspects related to the functioning of the Division and related aspects.
Pharmexcil is not under the administrative control of the government since it is an industry body and enjoys autonomy in administrative matters for creation of posts, service matters etc. However, the function of such EPCs are governed by para 2.55 of FTP 2015-20